Meet ‘Iron Boy’: Hempfield Twp. boy fighting cancer is real superhero – Gettysburg Times
Posted: November 27, 2020 at 1:47 pm
Alex Vucish is a superhero. He has nearly one million Tik Tok views of him dancing as Iron Man, and a comic book artist painted a picture of him with Iron Man and titled it My Iron Boy.
What makes him a real hero, though, is that Alex, the son of Michael and Jessica Vucish of Hempfield Township, is not fighting off imaginary bad guys.
Since May, Alex has been fighting for his life.
Doctors at Childrens Hospital of Pittsburgh started him today on an intravenous drip of his own harvested stem cells. Thats part of the continuing battle against the neuroblastoma that invaded his stomach and impacted adjacent organs. He nearly died when side effects of one treatment landed him on life support.
There were many times that we werent sure if he was going to be with us, his mother said.
But after a series of surgeries, treatments, and chemotherapy, things are looking more promising for the boy who turned three in July.
Alex is the strongest person I know and we are going to fight this with everything we have. We will never give up until the day we can say All Done to cancer and we can all breathe again, Jessica Vucish wrote on his public Facebook page, Alex Strong 2020.
Her sons journey has been followed by people all over the world who send encouragement and prayers. The family credits that with holding them together through the toughest times that a child could ever experience.
His symptoms began earlier this year when he didnt want to eat and his sleep was interrupted with bouts of screaming. Several visits to his pediatrician did not bring any diagnosis nor relief.
Jessica Vucish gave birth to their second child, Dominic, on April 20, and soon after, Alexs condition worsened. He lost weight, his stomach was distended, and he was constantly crying. They finally took him to the emergency department at Excela Westmoreland Hospital on May 9.
They took one x-ray and immediately sent us to Childrens Hospital, said Jessica Vucish, who rode in the ambulance with him.
Because of COVID-19, only one parent was permitted in the hospital, so her husband and his mother, Lisa Jacobelli of Jeannette, stayed back to take care of the baby.
Alex was admitted for a night filled with testing.
I think they did four ultrasounds, blood work and a CT scan, his mom said. I woke up at 7 a.m. it was Mothers Day and one of the nurses told me that the doctors found a mass, and that it was huge. It was the worst day of our lives.
Alex had stage 3 neuroblastoma, a cancer that develops from immature nerve cells and most commonly strikes children under the age of 5. His had grown to about five by seven inches in his stomach.
We were totally not prepared for this, Jessica Vucish said. The oncologist came up with a plan, that ok, were going to fight this. For the first two weeks we really mourned the cancer diagnosis and we mourned what he was going through. By the end of the second week, we were thinking, We can beat this.
Surgery confirmed the diagnosis, then chemotherapy started immediately to shrink the tumor. The parents signed papers acknowledging the possible side effects, including death.
We were taken aback by how severe everything ended up, his mom said. Alexs stomach became more distended after the first two days of treatment. The chemo sent him into a downward spiral. The tumor had soaked up Alexs blood and oozed it out into his abdomen. It was wrapped around his organs and that sent him into liver failure. His heart rate went up to 198 and he started foaming at the mouth.
He was rushed to the intensive care unit and put on life support. His organs were failing and the edema (doctors removed three liters of fluid) was almost collapsing his lungs. He was so sick that despite pandemic restrictions, both parents and his grandparents were called to his bedside to say goodbye.
We were prepared to lose him, Jessica Vucish said. I remember being told that we were lucky to have him for the time that we did, and that we had to let him go.
But Alex wasnt going anywhere. He was upgraded from the ICU two weeks later and soon resumed a total of six rounds of chemo. In all, he had three stem cell harvests, another stay in ICU, four visits to the emergency room, and the latest chemo to destroy his immunity in preparation for a bone marrow transplant. There also were seven surgeries, including a 16-hour operation to remove the tumor after round 4 of chemo. That left him with a triangle shaped scar similar to what Iron Man has on his chest from near fatal injuries.
Alex already loved Iron Man. His mother found the superhero costume for him to wear on Halloween and took a video of him dancing. When Tik Tok star Jennings Brower saw it, he got a video of a group of people dancing and posted it side by side with Alexs video.
When comic book inker Romeo Tanghal of New Jersey heard about Alex, he created a portrait of the boy with Iron Man and donated it to the family. Tanghal has an extensive rsum with DC Comics, Marvel Comics and others, including illustrating Batman, the Green Lantern, Star Trek and Wonder Woman.
The love and response from the community and from people we dont even know has been absolutely humbling, Jessica Vucish said.
That included a parade of emergency vehicles and other well-wishers that went by when he was home for his third birthday in July.
Alex will remain in isolation for weeks, possibly longer, to avoid infection, and his mother is staying with him for the first two weeks. Shes not permitted to leave the room. Shes a photographer and lost many sessions because of the pandemic, and that gives her time to spend with her son.
Her husband is involved in the family business, Stellar Precision Components in Jeannette, and is working from home. Hell spend the next block of time with Alex until his wife returns.
Vucish hopes that Alex wont remember the worst of the times all of the procedures that frightened him and that hell remember only that he survived. Hes now in the NED phase, which stands for No Evidence of Disease. But his parents know that the tumor can recur.
Everything thats happening is scary, his mom said. But you just have to do it one day at a time because the only other choice is to not do anything. We would much rather fight for his life.
Read this article:
Meet 'Iron Boy': Hempfield Twp. boy fighting cancer is real superhero - Gettysburg Times
- Unlocking The Unlimited Potential Of Stem Cells - CodeBlue - January 9th, 2021
- Hemostemix steps into the new year with capital and its critical clinical study data in hand - InvestorIntel - January 9th, 2021
- Global Organ and Tissue Transplantation and Alternatives Market to 2024 - Impact Analysis of COVID-19 - Yahoo Finance - January 9th, 2021
- Top 10 ALS Stories of 2020 - ALS News Today - January 9th, 2021
- Brave West Lothian women discovers back pain is actually deadly blood cancer - Daily Record - January 9th, 2021
- Global Bone Marrow Aspirate Concentrates (BMAC) Market : Industry Analysis and forecast (2019 to 2026): By product Type, Application, End Users, and... - January 9th, 2021
- Creative Medical Technology Holdings Announces Successful Application of ImmCelz Immunotherapy for Treatment of Stroke - PRNewswire - December 22nd, 2020
- Organ and Tissue Transplantation and Alternatives - GlobeNewswire - December 22nd, 2020
- How Researchers Are Making Do in the Time of COVID-19 - The Wire Science - December 22nd, 2020
- FDA Resumes eIND Approval for Severe-to-Critical COVID-19 Patients Use of Vyrologix (leronlimab) Following Full Enrollment in CytoDyn's Phase 3 Trial... - December 22nd, 2020
- Priming the Immune System to Fight Cancer - PRNewswire - December 22nd, 2020
- The 11 most mind-blowing, awe-inspiring health discoveries and innovations of 2020 - Business Insider - Business Insider - December 22nd, 2020
- Orchard Therapeutics Receives EC Approval for Libmeldy for the Treatment of Early-Onset Metachromatic Leukodystrophy (MLD) - GlobeNewswire - December 22nd, 2020
- Creative Medical Technology Stock Price Increased 80.77%: Why It Happened - Pulse 2.0 - December 22nd, 2020
- Digenic mutations in ALDH2 and ADH5 impair formaldehyde clearance and cause a multisystem disorder, AMeD syndrome - Science Advances - December 22nd, 2020
- Creative Medical Technology Holdings Announces Successful Application of ImmCelz Immunotherapy for Treatment of Stroke - KPVI News 6 - December 16th, 2020
- Novel class of targeted cancer therapies could treat myeloid leukaemias - Drug Target Review - December 16th, 2020
- 1st Patients To Get CRISPR Gene-Editing Treatment Continue To Thrive - NPR - December 16th, 2020
- Bone Regeneration Material Market: Cell-based Segment to Expand Significantly - BioSpace - December 16th, 2020
- Shingles: What triggers this painful, burning rash? - Harvard Health Blog - Harvard Health - December 16th, 2020
- Impact of Covid-19 On Orthopedic Regenerative Medicine Market Business Overview and Forecast to 2027 | Curasan, Inc., Carmell Therapeutics... - December 16th, 2020
- Early Signs of Activity and Tolerability Found in Allogeneic Product UCART22 for Patients with Relapsed/Refractory CD22+ B-Cell ALL - Cancer Network - December 16th, 2020
- Updated Findings Show Continued Efficacy for CAR T-Cell Therapy in Heavily Pretreated Myeloma - Targeted Oncology - December 16th, 2020
- Haywards Heath woman's bid to fund stem cell treatment to combat MS - Mid Sussex Times - December 16th, 2020
- Stem Cell Transplant Reduces Relapses and Disability in RRMS... - Multiple Sclerosis News Today - December 11th, 2020
- Gamida Cell Provides Pipeline Update, Including Detailed Results of Pivotal Phase 3 Clinical Study of Omidubicel, and Prepares to Start BLA Submission... - December 11th, 2020
- Groundbreaking Trial On Children With Brain Injuries In Madrid - Euro Weekly News - December 11th, 2020
- Actinium Highlights Iomab-B Safety Data Presented at the 62nd American Society of Hematology Annual Meeting - Yahoo Finance - December 11th, 2020
- Antileukemic Activity Seen With Flotetuzumab in Primary Induction Failure, Early-Relapse AML - Hematology Advisor - December 11th, 2020
- SNUH finds way to produce T-cells to prevent HSCT complications - Korea Biomedical Review - December 11th, 2020
- CLL patients in England to get AZ's Calquence after okay from NICE - - pharmaphorum - December 11th, 2020
- JP Duminy goes to bat for the SA Bone Marrow Registry - IOL - December 10th, 2020
- Donor Stem Cell Transplant Improves Survival in Older Patients with Myelodysplastic Syndrome - Cancer Health Treatment News - December 10th, 2020
- City of Hope Doctors Present Innovative Therapies to Better Treat Blood Cancers at American Society of Hematology Virtual Conference - Business Wire - December 10th, 2020
- Jasper Therapeutics Announces Data from First Transplant-naive Patient in Phase 1 Clinical Trial of JSP191 as Conditioning Agent in Patients with SCID... - December 10th, 2020
- Bid to fund stem cell treatment in Mexico for woman with MS - Bournemouth Echo - December 10th, 2020
- The Technology Behind Bone Marrow Cellular Processing: The PXP System - Marketscreener.com - December 10th, 2020
- ElevateBio's HighPassBio Presents on Novel T Cell Receptor Cell Therapy for Leukemia Relapse at 62nd Annual ASH Meeting - Business Wire - December 10th, 2020
- Gene Therapy, Absolutely and For Real | In the Pipeline - Science Magazine - December 10th, 2020
- Negrin Shines Light on the Orca-T Story in GVHD - OncLive - December 10th, 2020
- Researchers Trace the Origin of Blood Cancer to Early Childhood, Decades before Diagnosis - PRNewswire - December 10th, 2020
- Magenta Therapeutics Announces Commencement of First Phase 2 Clinical Trial of MGTA-145 for Stem Cell Mobilization, Oral Presentation of MGTA-145... - December 10th, 2020
- Hadassah Medical Center and Neurogenesis Announce Groundbreaking Results from a Phase 2 Study in Progressive Multiple Sclerosis treated with NG-01... - December 10th, 2020
- Rocket Pharmaceuticals Presents Positive Clinical Data from its Fanconi Anemia and Leukocyte Adhesion Deficiency-I Programs at the 62nd American... - December 10th, 2020
- Venetoclax/Azacitidine Combination Efficacious for the Treatment of Older Patients With Higher-Risk Myelodysplastic Syndrome - Oncology Nurse Advisor - December 10th, 2020
- Precigen Presents New Data Supporting the Safety, Clinical Activity, Expansion and Persistence of PRGN-3006 UltraCAR-T at the 62nd ASH Annual Meeting... - December 10th, 2020
- BeyondSpring Announces New Positive PROTECTIVE-2 Phase 3 Registrational Trial Results at the 2020 San Antonio Breast Cancer Symposium - BioSpace - December 10th, 2020
- Joliet 2-year-old gets pre-holiday gift: tests that show he's cancer-free - The Herald-News - December 10th, 2020
- Preliminary Results from NexImmune's Phase 1/2 Trial of NEXI-001 in AML Presented at 62nd ASH Annual Meeting and Exposition - GlobeNewswire - December 10th, 2020
- How do you donate stem cells? Donating cells can help treat cancer, blindness and other conditions - heres how - The Scotsman - December 4th, 2020
- Repairing the Brain With Stem Cells? A Conversation With Prof. Jack Price - Being Patient - December 4th, 2020
- Treatment to restore vision by injecting stem cells into the eye could help people with damaged eyesight - iNews - December 4th, 2020
- Sphingosine 1-phosphate Receptor Modulator ONO-4641 Regulates Trafficking of T Lymphocytes and Hematopoietic Stem Cells and Alleviates Immune-Mediated... - December 4th, 2020
- Cancer center is a contributor to 49 research studies at the 62nd American Society of Hematology Annual Meeting - Newswise - December 4th, 2020
- IN8bio announces first-in-human Phase 1 trial Update from The University of Kansas Cancer Center using INB-100, IN8bios Gamma Delta T-cell product... - December 4th, 2020
- Bone Marrow Transplant Market Size, Segmented by Type of Deployment, Application, And Region Growth, Trends, And Forecast - The Haitian-Caribbean... - December 4th, 2020
- Gut bacteria can help rebuild the immune system - Medical News Today - December 4th, 2020
- InvestmentPitch Media Video Discusses Hemostemix Successfully Obtaining all Clinical Trial Data and Announcement of $2.5 Million Unit Offering - Video... - December 4th, 2020
- Outlook on the Multiple Myeloma Drugs Global Market to 2025 - by Therapy, Drug Type, End-user, Distribution Channel and Region -... - December 4th, 2020
- Imago BioSciences Expands Phase 2 Clinical Trial of Bomedemstat (IMG-7289) for the Treatment of Myelofibrosis into Hong Kong - Business Wire - December 4th, 2020
- The New Coronavirus Vaccine Is Changing The Future Of Medicine - Forbes - December 4th, 2020
- Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate Safety and Therapeutic Efficacy of Angiogenesis Induced by Intraarterial Autologous... - November 30th, 2020
- How are bones and the heart connected? - British Heart Foundation - November 30th, 2020
- Telix Pharmaceuticals Limited Acquires TheraPharm GmbH, Broadening Reach to Hematologic Cancers and Transplant Medicine - BioSpace - November 30th, 2020
- Global Hematopoietic Stem Cell Transplantation (HSCT) Market 2020 Impact of COVID-19, Future Growth Analysis and Challenges | Regen Biopharma Inc,... - November 30th, 2020
- Coronavirus Updates: The Latest Treatments and Vaccines - GovTech - November 30th, 2020
- Hematopoietic Stem Cell Transplantation (HSCT) Market To Witness Huge Growth By 2027 | Regen Biopharma Inc, China Cord Blood Corp, CBR Systems Inc,... - November 30th, 2020
- Bone Marrow Processing Systems Market Top Participant to Focus on Regional Expansion - Murphy's Hockey Law - November 30th, 2020
- Family 'over the moon' as nine-year-old Aurora confirmed as being back in remission - The Isle of Thanet News - November 30th, 2020
- Pilot study finds potential signal indicative of loss of tone in blood vessels after cardiac surgery - The Hindu - November 30th, 2020
- Family's joy as schoolgirl, 9, back in remission - Kent Online - November 30th, 2020
- Family's heartache after Hebburn boy diagnosed with one in a million condition - Chronicle Live - November 30th, 2020
- Raleigh man delivers stem cells to patients around the world - WRAL.com - November 28th, 2020
- US FDA Approves Naxitamab for the Treatment of Neuroblastoma - OncoZine - November 28th, 2020
- The roles bone marrow plays in the body - Therogersvillereview - November 27th, 2020
- Severe Infections Wreak Havoc on Mouse Blood Cell Production - Technology Networks - November 27th, 2020
- Revenue from the Sales of Hematopoietic Stem Cells Transplantation Market to Witness Relatively Significant Growth During 2017 2025 - Canaan Mountain... - November 27th, 2020
- Approval of Phase I/II Clinical Trial of ATG-016 (Eltanexor), a Second Generation Selective Inhibitor of Nuclear Export (SINE), in Mainland China for... - November 27th, 2020
- G1 Therapeutics: Depressed Price Before Catalyst, No Apparent Reason - Seeking Alpha - November 27th, 2020
- Impact of COVID 19 on Orthopedic Regenerative Medicine Market Detailed Research Study 2020-2027 | Curasan, Inc., Carmell Therapeutics Corporation,... - November 27th, 2020